Author:
Jin Xi-Han,Lu Sen,Wang Ai-Fen
Abstract
Abstract
Background
This study sought to detect the expression and clinical significance of miR-4516 and miR-21-5p in serum of patients with colorectal cancer.
Methods
Bioinformatics methods were used to analyze the expression patterns of miR-4516 and miR-21-5p in colorectal cancer. A total of 80 patients with colorectal cancer, 65 patients with benign colorectal tumors and 50 healthy persons were selected. qRT-PCR was performed to detect the expression levels of serum miR-4516 and miR-21-5p before and after operation or postoperative recurrence. The correlation of miR-4516 and miR-21-5p expression levels with the clinical characteristics and prognosis of colorectal cancer was analyzed, and that with the patient’s survival was further examined by Kaplan-Meier analysis.
Results
MiR-4516 was poorly expressed in colorectal cancer in the preoperative group, and miR-21-5p was highly expressed. While in the postoperative group, miR-4516 was up-regulated, and miR-21-5p was down-regulated. The low expression of miR-4516 was shown to be related to TNM staging, invasion degree, lymph node metastasis and distant metastasis of the patients. Whereas the high expression of miR-21-5p was proved to be correlated with TNM staging and lymph node metastasis. Kaplan-Meier survival analysis showed that high expression of miR-4516 or low expression of miR-21-5p could contribute to better overall survival.
Conclusion
Low miR-4516 or high miR-21-5p could be used as an independent risk factor for prognosis of colorectal cancer.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Oncology
Reference19 articles.
1. Fang Q, Qu A, Zhang X, Du L, Yang Y, Wang C. Expression and clinical significance of miR-210 in the serum of patients with colorectal cancer. J Shandong University (Health Sciences). 2015;06:77–81.
2. Chen Z, Huang Z, Jin R. Expression and clinical significance of LRG1in the serum of patients with colorectal cancer. China Modern Doctor. 2017;26:1–3.
3. Ebrahimi F, Gopalan V, Wahab R, Lu C-T, Smith RA, Lam AK-Y. Deregulation of miR-126 expression in colorectal cancer pathogenesis and its clinical significance. Exp Cell Res. 2015;339(2):333–41.
4. Meister J. Schmidt MHH: miR-126 and miR-126*: new players in cancer. Scientific World J. 2010;10:2090–100.
5. Moles R. MicroRNAs-based therapy: a novel and promising strategy for Cancer treatment. Microrna. 2017;6(2):102–9.
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献